157 related articles for article (PubMed ID: 30700239)
1. [Epidemiology and socio-economic aspects of chronic inflammatory bowel diseases in Switzerland].
Schoepfer A; Safroneeva E
Ther Umsch; 2019 Jan; 75(5):255-259. PubMed ID: 30700239
[TBL] [Abstract][Full Text] [Related]
2. Chronic comorbidities associated with inflammatory bowel disease: prevalence and impact on healthcare costs in Switzerland.
Bähler C; Schoepfer AM; Vavricka SR; Brüngger B; Reich O
Eur J Gastroenterol Hepatol; 2017 Aug; 29(8):916-925. PubMed ID: 28471826
[TBL] [Abstract][Full Text] [Related]
3. The cost of illness analysis of inflammatory bowel disease.
Pakdin M; Zarei L; Bagheri Lankarani K; Ghahramani S
BMC Gastroenterol; 2023 Jan; 23(1):21. PubMed ID: 36658489
[TBL] [Abstract][Full Text] [Related]
4. Trends in prevalence, mortality, health care utilization and health care costs of Swiss IBD patients: a claims data based study of the years 2010, 2012 and 2014.
Bähler C; Vavricka SR; Schoepfer AM; Brüngger B; Reich O
BMC Gastroenterol; 2017 Dec; 17(1):138. PubMed ID: 29197335
[TBL] [Abstract][Full Text] [Related]
5. The Evolution of Health Care Utilisation and Costs for Inflammatory Bowel Disease Over Ten Years.
Pillai N; Dusheiko M; Maillard MH; Rogler G; Brüngger B; Bähler C; Pittet VEH;
J Crohns Colitis; 2019 May; 13(6):744-754. PubMed ID: 30916775
[TBL] [Abstract][Full Text] [Related]
6. Viewpoint: Inflammatory Bowel Diseases Among Immigrants From Low- to High-Incidence Countries: Opportunities and Considerations.
Agrawal M; Burisch J; Colombel JF; C Shah S
J Crohns Colitis; 2020 Feb; 14(2):267-273. PubMed ID: 31359034
[TBL] [Abstract][Full Text] [Related]
7. Trends in hospitalisation rates for inflammatory bowel disease in western versus newly industrialised countries: a population-based study of countries in the Organisation for Economic Co-operation and Development.
King JA; Underwood FE; Panaccione N; Quan J; Windsor JW; Kotze PG; Ng SC; Ghosh S; Lakatos PL; Jess T; Panaccione R; Seow CH; Ben-Horin S; Burisch J; Colombel JF; Loftus EV; Gearry R; Halfvarson J; Kaplan GG
Lancet Gastroenterol Hepatol; 2019 Apr; 4(4):287-295. PubMed ID: 30765267
[TBL] [Abstract][Full Text] [Related]
8. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
Burisch J
Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
[TBL] [Abstract][Full Text] [Related]
9. Costs of inflammatory bowel disease in Germany.
Stark R; König HH; Leidl R
Pharmacoeconomics; 2006; 24(8):797-814. PubMed ID: 16898849
[TBL] [Abstract][Full Text] [Related]
10. Direct health-care cost utilization in Hong Kong inflammatory bowel disease patients in the initial 2 years following diagnosis.
Mak LY; Ng SC; Wong IOL; Li MKK; Lo FH; Wong MTL; Leung CM; Tsang SWC; Chan KH; Sze SF; Shan EHS; Lam BCY; Hui AJ; Hung IFN; Leung WK
J Gastroenterol Hepatol; 2018 Jan; 33(1):141-149. PubMed ID: 28475813
[TBL] [Abstract][Full Text] [Related]
11. Association of urinary phenolic compounds, inflammatory bowel disease and chronic diarrheal symptoms: Evidence from the National Health and Nutrition Examination Survey.
de Silva PS; Yang X; Korzenik JR; Goldman RH; Arheart KL; Caban-Martinez AJ
Environ Pollut; 2017 Oct; 229():621-626. PubMed ID: 28689150
[TBL] [Abstract][Full Text] [Related]
12. Coping is excellent in Swiss Children with inflammatory bowel disease: results from the Swiss IBD cohort study.
Rogler D; Fournier N; Pittet V; Bühr P; Heyland K; Friedt M; Koller R; Rueger V; Herzog D; Nydegger A; Schäppi M; Schibli S; Spalinger J; Rogler G; Braegger CP;
J Crohns Colitis; 2014 May; 8(5):409-20. PubMed ID: 24230970
[TBL] [Abstract][Full Text] [Related]
13. The Search for Causative Environmental Factors in Inflammatory Bowel Disease.
Rogler G; Zeitz J; Biedermann L
Dig Dis; 2016; 34 Suppl 1():48-55. PubMed ID: 27548430
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of inflammatory bowel disease in an insured population in Puerto Rico during 1996.
Torres EA; De Jesús R; Pérez CM; Iñesta M; Torres D; Morell C; Just E
P R Health Sci J; 2003 Sep; 22(3):253-8. PubMed ID: 14619451
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of anaemia in inflammatory bowel disease in Switzerland: a cross-sectional study in patients from private practices and university hospitals.
Voegtlin M; Vavricka SR; Schoepfer AM; Straumann A; Voegtlin J; Rogler G; Ballabeni P; Pittet V; Buser A; Fried M; Beglinger C;
J Crohns Colitis; 2010 Dec; 4(6):642-8. PubMed ID: 21122574
[TBL] [Abstract][Full Text] [Related]
16. [Incidence of inflammatory bowel diseases in Bretagne (1994-1995). ABERMAD. Association Bertonne d'Etude et de Recherche des Maladies de l'Appareil Digesif].
Pagenault M; Tron I; Alexandre JL; Cruchant E; Dabadie A; Chaperon J; Robaszkiewicz M; Bretagne JF
Gastroenterol Clin Biol; 1997; 21(6-7):483-90. PubMed ID: 9295976
[TBL] [Abstract][Full Text] [Related]
17. A national survey on the patterns of treatment of inflammatory bowel disease in Canada.
Hilsden RJ; Verhoef MJ; Best A; Pocobelli G
BMC Gastroenterol; 2003 Jun; 3():10. PubMed ID: 12791168
[TBL] [Abstract][Full Text] [Related]
18. Incidence and phenotype at diagnosis of inflammatory bowel disease. Results in Spain of the EpiCom study.
Fernández A; Hernández V; Martínez-Ares D; Sanromán L; de Castro ML; Pineda JR; Carmona A; González-Portela C; Salgado C; Martínez-Cadilla J; Pereira S; García-Burriel JI; Vázquez S; Rodríguez-Prada I;
Gastroenterol Hepatol; 2015 Nov; 38(9):534-40. PubMed ID: 25890448
[TBL] [Abstract][Full Text] [Related]
19. The socio-economic impact of work disability due to inflammatory bowel disease in Brazil.
de S B Fróes R; Carvalho ATP; de V Carneiro AJ; de Barros Moreira AMH; Moreira JPL; Luiz RR; de Souza HS
Eur J Health Econ; 2018 Apr; 19(3):463-470. PubMed ID: 28523493
[TBL] [Abstract][Full Text] [Related]
20. [Changes in the epidemiology of inflammatory bowel diseases].
Lakatos L; Lakatos PL
Orv Hetil; 2007 Feb; 148(5):223-8. PubMed ID: 17344143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
